EN
HI
Summary
As of 4 Sep, 2026, Alembic Pharmaceuticals stock price is ₹803.65. During the trading session, the stock has moved between an intraday low of ₹801.10 and an intraday high of ₹833.50. Over the last 52 weeks, Alembic Pharmaceuticals has traded between ₹635.80 and ₹998.00.
The stock has recorded a trading volume of 1,63,761 shares, with a market capitalization of ₹196563124. Its Average Traded Price (ATP) is ₹812.72, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹803.65.
Alembic Pharmaceuticals has an upper circuit limit of ₹992.25 and a lower circuit limit of ₹661.55. The total value traded stands at ₹13.31 CR, and the delivery percentage for the day is 41.11%.
The stock is currently traded with a market lot size of 1. Alembic Pharmaceuticals also offers a dividend yield of 1.45%.
Alembic Pharmaceuticals share price chart
Alembic Pharmaceuticals Share Key Metrics
Volume
1.64 L
Market Cap
15796.80 CR
LTQ@LTP
1@803.65
ATP
812.72
Var Margin
15.56 %
Circuit Range
661.55-992.25
Delivery %
41.11 %
Value
13.31 CR
ASM/GSM
No
Market Lot
1
Alembic Pharmaceuticals Fundamentals
P/E Ratio
23.42
P/B Ratio
2.78
Div. Yield
1.45
Sector P/E
41.68
Sector P/B
3.55
Sec. Div. Yield
0.5
Alembic Pharmaceuticals Resistance and Support
Pivot 836.38
Resistance
First Resistance
849.51
Second Resistance
872.13
Third Resistance
885.26
Support
First Support
813.76
Second Support
800.63
Third Support
778.01
Alembic Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Sep 03 2026 | 833.5 | 803.65 | -2.81% | 833.5 | 801.1 |
| Wed Sep 02 2026 | 845 | 826.9 | -2.01% | 859 | 823.25 |
| Tue Sep 01 2026 | 835 | 843.84 | 1.07% | 847.84 | 825.54 |
Alembic Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-04 | Quarterly Results |
| 2026-05-15 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-04 | Quarterly Results & Others |
| 2025-08-05 | Quarterly Results & Others |
| 2025-05-06 | Audited Results & Final Dividend |
| 2025-02-03 | Quarterly Results & Others |
| 2024-11-07 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
Alembic Pharmaceuticals Management
| Name | Position |
|---|---|
| Chirayu Amin | Chairman & CEO |
| Pranav Amin | Managing Director |
Alembic Pharmaceuticals Similar Stocks
Alembic Pharmaceuticals FAQs
The Buying Price of Alembic Pharmaceuticals share is 803.65 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Alembic Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alembic Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Alembic Pharmaceuticals shares is 23.42. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Alembic Pharmaceuticals shares is 2.78. Useful to assess the stock's value relative to its book value.
To assess Alembic Pharmaceuticals’s valuation compare Sector P/E, P/B which are 41.68 & 3.55 with sector averages, along with growth rates and financial metrics.
The Market Cap of Alembic Pharmaceuticals is 15796.80 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Alembic Pharmaceuticals share price is 998.00 & 635.80. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Alembic Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
